Weed (BUDZ) Income towards Parent Company (2010 - 2026)
Weed (BUDZ) recorded quarterly Income towards Parent Company of -$175256.0 in Q1 2026, up 76.64% quarter-over-quarter from -$750188.0 in Q4 2025, and up 60.21% on a YoY basis from -$109391.3 in Q1 2025.
Weed (BUDZ) Income towards Parent Company (2010 - 2026) Analysis & Trends
Weed's Income towards Parent Company history runs 13 years deep, the most recent figure standing at -$175256.0 for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 60.21% year-over-year to -$175256.0; the TTM figure through Mar 2026 stood at -$1.1 million (down 41.83% YoY), while the FY2025 annual figure was -$1.4 million, down 168.68% from the prior year.
- Income towards Parent Company was -$175256.0 for Q1 2026 at Weed, up from -$750188.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $768714.0 in Q4 2023 to a low of -$750188.0 in Q4 2025.
- Historically, Income towards Parent Company has averaged -$208026.2 across 5 years, with a median of -$175256.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Income towards Parent Company soared 348.42% in 2023, then slumped 463.1% in 2025.
- A 5-year view of Income towards Parent Company shows it stood at -$309436.0 in 2022, then surged by 348.42% to $768714.0 in 2023, then slumped by 117.33% to -$133224.0 in 2024, then plunged by 463.1% to -$750188.0 in 2025, then soared by 76.64% to -$175256.0 in 2026.
- The last three Income towards Parent Company figures came in at -$175256.0 (Q1 2026), -$750188.0 (Q4 2025), and -$73946.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Weed | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -175,256.00 |
| Dec 31, 2025 | -750,188.00 |
| Sep 30, 2025 | -73,946.00 |
| Jun 30, 2025 | -107,616.00 |
| Mar 31, 2025 | -440,455.00 |
| Dec 31, 2024 | -133,224.00 |
| Sep 30, 2024 | -95,887.00 |
| Jun 30, 2024 | -110,953.00 |
| Mar 31, 2024 | -170,652.00 |
| Dec 31, 2023 | 768,714.00 |
| Sep 30, 2023 | -254,127.00 |
| Jun 30, 2023 | -173,443.00 |
| Mar 31, 2023 | -197,014.00 |
| Dec 31, 2022 | -309,436.00 |
| Sep 30, 2022 | -308,990.00 |
| Jun 30, 2022 | -426,751.00 |
| Mar 31, 2022 | -577,221.00 |
| Dec 31, 2021 | -447,639.00 |
| Sep 30, 2021 | -173,325.00 |
| Jun 30, 2021 | -1.22 Mn |